Benzinga | Nov 12, 2021 07:47AM EST

Humacyte Q3 EPS $(0.72) Up From $(3.07) YoY, Grant Sales $241.00K Down From $914.00K YoY

Humacyte (NASDAQ:HUMA) reported quarterly losses of $(0.72) per share. This is a 76.55 percent increase over losses of $(3.07) per share from the same period last year. The company reported $241.00 thousand in sales this quarter. This is a 73.63 percent decrease over sales of $914.00 thousand the same period last year.